drugset / Trial / NCT02514200
Treatment of Keratoconus With Advanced CXL-II
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether individualized, topography-based corneal crosslinking for keratoconus can improve the optical outcomes of the treatment.
Timeline
- Start
- 2014-03
- Primary completion
- 2019-10
- Completion
- 2019-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Riboflavin | Other / unclassified | — | Topical |